NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research ChannelBioSpace Collaborative Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Altair Therapeutics 

150 Spear Street
Suite 1050
San Francisco  California  94105  U.S.A.
Phone: 415-541-8600 Fax: 415-541-8980


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma 11/19/2009 8:34:54 AM    More...
Altair Therapeutics Secures $17 Million Financing 11/11/2009 1:36:59 PM    More...
Altair Therapeutics Reports Successful Phase I Study of Inhaled AIR645 9/14/2009 9:07:36 AM    More...
Altair Therapeutics Reports Successful Completion of Phase I Study of Inhaled AIR645 5/18/2009 8:30:54 AM    More...
Altair Therapeutics Appoints Dr. Joel Martin President and CEO 5/14/2009 11:04:07 AM    More...
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics 12/18/2007 11:30:43 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) and Thomas, McNerney & Partners Announce Plans for Newly Formed Altair Therapeutics 10/16/2007 10:15:00 AM    More...